Copyright © 2015 - 2022 Lifecarenews.in
LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Copyright © 2015 - 2022 Lifecarenews.in
LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Recover your password.
A password will be e-mailed to you.
Q1 2022/23
Interim financial results, Q1 2022/23
1 October 2022 – 31 December 2022
Coloplast delivered a solid start to the year with 7% organic growth and a 29% EBIT margin before special items
FY 2022/23 financial guidance – unchanged organic revenue growth of 7-8% and an EBIT margin of 28-30% before special items. Reported revenue growth adjusted to 9-10%.
”We deliver a solid start to the year with 7% organic growth and an EBIT margin of 29% in Q1, in line with our financial guidance. Our Chronic Care business delivered a strong first quarter with broad-based growth excluding China. I would like to highlight our strong performance in Ostomy Care in the US where we continue to strengthen our competitive position, latest with a three-year renewal of our group purchasing agreement with Premier Inc. I am also pleased with our continued solid performance in our Interventional Urology and Voice and Respiratory Care businesses. Finally, we are launching our new male intermittent catheter Luja™, designed to reduce the risk of urinary tract infections. I am excited by what I believe Luja can do for people using intermittent catheters as well as healthcare systems,” says President and CEO Kristian Villumsen.
Conference call
Coloplast will host a conference call on Friday, 03 February 2023 at 11.00 CET.
For further information, please contact
Investors and analysts
Aleksandra Dimovska
Kristine Husted Munk
Press and media
Address
Website
This announcement is available in a Danish and an English-language version. In the event of discrepancies, the English version shall prevail.
Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate health care. Our business includes Ostomy Care, Continence Care, Wound and Skin Care, Interventional Urology and Voice and Respiratory Care. We operate globally and employ more than 14,500 employees.
The Coloplast logo is a registered trademark of Coloplast A/S. © 2023-02. |
Get real time updates directly on you device, subscribe now.